TNF-α production in whole blood may be a specific indicator of sputum conversion at 6 months in patients with MDR-TB [22], and using TNF-α inhibitors is accompanied by an increased susceptibility to active TB or reactivation of a latent TB infection [23]. This evidence concerns the gene TNF and multidrug-resistant tuberculosis.